Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Open-Label Study of Effects on Responsive Neurostimulator Activity After Intranasal Administration of Single Dose of Valtoco® to People With Epilepsy

NCT05273398 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT05273398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Open-Label Study of Effects on Responsive Neurostimulator Activity After Intranasal Administration of Single Dose of Valtoco® to People With Epilepsy
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2022
Completion date
November 10, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsies, partial